Generation of animal models sensitive to SARS-CoV-2 to test vaccines or drugs (hACE2-COV project)
- Funded by Institut Pasteur International Network (IPIN)
- Total publications:0 publications
Grant number: hACE2-COV
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Institut Pasteur International Network (IPIN)Research Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Aim - Rapid development of animal models is of utmost importance to test the efficacy of vaccines and drug against COVID-19. The aim of this research project is to propose models whose cells express the human ACE2 proteins (huACE2) so that they are sensitive to SARS-CoV-2. The ACE2 protein is the gateway for the virus to enter cells. Researchers are proposing to use adenoviruses and lentiviruses as a vector to introduce the huACE2 gene.